/content/dam/www/people-profile-photos/e/robert-eisenman/robert-eisenman-d.jpg
Eisenman
Robert N. Eisenman, PhD

Robert N. Eisenman, PhD

  • Professor, Basic Sciences Division, Fred Hutch
  • Member, Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch
206.667.4445
206.667.6522
Eisenman Lab

Background

Dr. Robert "Bob" Eisenman’s research is focused on the MYC network: a group of genes that are important for normal growth and development but, when mutated, are profoundly involved in a multitude of human cancers. All of these factors encode gene-regulatory proteins that control cellular programs in response to signals from the environment. Dr. Eisenman’s laboratory uses genetic and molecular analyses to understand in detail the functions of these proteins and the pathways they control with the eventual goal of modulating their functions as a means of treating cancers.

Education

Postdoctoral, Massachusetts Institute of Technology, Cell Biology, 1976

Postdoctoral, Institut Suisse de Recherche Experimentale sur le Cancer, Virology, 1975

PhD, University of Chicago, Biophysics, 1971

Find a Clinical Trial

View All Trials

Stories

All news
Showcasing new strides in rare cancer research
Showcasing new strides in rare cancer research Fred Hutch 4th Rare Cancers Symposium features local and national experts in critical research areas including immunotherapy, clinical trial design and biobanking October 31, 2025
Cell biologist and former Fred Hutch division leader Dr. Jonathan Cooper retires
Cell biologist and former Fred Hutch division leader Dr. Jonathan Cooper retires Cooper sustained the distinct culture of Basic Sciences for four decades March 26, 2025
In cancer, the context 'makes' the mutation
In cancer, the context 'makes' the mutation Whether a mutated gene suppresses or promotes small-cell lung cancer depends on other mutations June 1, 2020